Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Global Trends in Resistance to Antituberculosis Drugs
2001519 citationsMarcos Espinal, A László et al.New England Journal of Medicineprofile →
Citations per year, relative to F Boulahbal F Boulahbal (= 1×)
peers
N Martín-Casabona
Countries citing papers authored by F Boulahbal
Since
Specialization
Citations
This map shows the geographic impact of F Boulahbal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Boulahbal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Boulahbal more than expected).
This network shows the impact of papers produced by F Boulahbal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Boulahbal. The network helps show where F Boulahbal may publish in the future.
Co-authorship network of co-authors of F Boulahbal
This figure shows the co-authorship network connecting the top 25 collaborators of F Boulahbal.
A scholar is included among the top collaborators of F Boulahbal based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with F Boulahbal. F Boulahbal is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Espinal, Marcos, A László, Lone Simonsen, et al.. (2001). Global Trends in Resistance to Antituberculosis Drugs. New England Journal of Medicine. 344(17). 1294–1303.519 indexed citations breakdown →
8.
Espinal, Marcos, Lone Simonsen, A László, et al.. (2000). Anti-tuberculosis Drug Resistance in the World: Report no. 2: Prevalence and Trends.38 indexed citations
9.
Trébucq, Arnaud, et al.. (1999). Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.. PubMed. 3(6). 466–70.25 indexed citations
Boulahbal, F, et al.. (1989). The interest of follow-up of resistance of the tubercle bacillus in the evaluation of a programme.. PubMed. 64(3). 23–5.19 indexed citations
Boulahbal, F, et al.. (1989). [Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis].. PubMed. 6(1). 59–64.4 indexed citations
14.
Tazir, Mériem, et al.. (1985). [Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].. PubMed. 2(4). 209–14.5 indexed citations
15.
Boulahbal, F, et al.. (1982). [Role of Mycobacterium tuberculosis in bovine tuberculosis].. PubMed. 53. 155–64.10 indexed citations
16.
Boulahbal, F, et al.. (1977). [Serum and cerebrospinal fluid levels of rifampicin (R AMP)].. PubMed. 50-51. 171–81.1 indexed citations
17.
Boulahbal, F, et al.. (1976). Prospective study of the organization and supervision of the bacteriological diagnosis of pulmonary tuberculosis in a case finding network in Algeria.. PubMed. 51(1). 313–21.3 indexed citations
18.
Martini, M, et al.. (1975). [Ascertained diagnosis in bone and bone-and-joint tuberculosis (author's transl)].. PubMed. 29(2). 111–7.2 indexed citations
19.
Martini, M, et al.. (1972). [Primary mycoses of tibia due to Nocardia asteroides].. PubMed. 58(8). 813–6.3 indexed citations
20.
Boulahbal, F & G Canetti. (1971). [Comparative study of the Ziehl-Neelsen and fluorescent microscopy methods of staining tubercle bacilli of excised pulmonary tissue].. PubMed. 49. 37–50.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.